Benign urinary system neoplasm
Therapeutic area
Nephrology
Rare disease
No
- Definition
- A non-metastasizing neoplasm that arises from the organs that comprise the urinary system. Representative examples include renal oncocytoma, bladder inverted papilloma, and urothelial papilloma.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Benign urinary system neoplasm
- Therapeutic area
- Nephrology
- benign urinary system neoplasm
- benign neoplasm of the urinary tract
- benign neoplasm of urinary tract
- benign tumor of the urinary tract
- benign tumor of urinary tract
- benign tumour of the urinary tract
- benign tumour of urinary tract
- benign urinary tract neoplasm
- benign urinary tract tumor
- benign urinary tract tumour
- renal system benign neoplasm
- neoplasm of urinary system
- tumor of the urinary system
- tumor of urinary tract
- tumour of the urinary system
- tumour of urinary tract
- urinary tract neoplasm
- Severity
- Mild
- Nephrology
- Oncology
Sources for recorded values
- MONDO ID
- MONDO:0004180
- Parent condition
- MONDO:0005165
Related records
Broader conditions (10)
- Benign neoplasm
- Cancer or benign tumor
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Human disease
- Neoplasm
- Neoplastic disease or syndrome
- Urinary system disorder
- Urinary system neoplasm
Narrower conditions (41)
- Benign cystic nephroma
- Benign mesonephroma
- Benign metanephric tumor
- Benign neoplasm of renal pelvis
- Benign prostate phyllodes tumor
- Benign urethral neoplasm
- Bladder benign neoplasm
- Bladder leiomyoma
- Bladder squamous papilloma
- Bladder urothelial papilloma
- Childhood kidney angiomyolipoma
- Chromophil adenoma of the kidney
- Hereditary kidney oncocytoma
- Inverted urothelial papilloma
- Kidney angiomyolipoma
- Kidney benign neoplasm
- Kidney lipoma
- Kidney oncocytoma
- Metanephric adenoma
- Minor vestibular glands adenoma
Trials (155)
- 2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen
- A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
- A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery
- A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
- A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
- A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium
- A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
- A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC)
- A Prospective, Single-Arm, Multicenter Clinical Study of High-Risk Localized and Locally Advanced Renal Clear Cell Carcinoma
- A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
- A Study of Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NMIBC Following TURBT
- A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract
- A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)
- A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Locally Advanced or Metastatic Urinary System Tumors
- A Study of Cadonilimab（AK104）Combined With Standard Treatment for Function Preservation in Urinary System Tumors
- A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer
- A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
- A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer
- A Study of Herceptin (Trastuzumab) Monotherapy in Patients With Metastatic Urothelial Cancer
- A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Approved drugs (3)
- Atezolizumab
- Enfortumab vedotin
- Vinflunine ditartrate